[Clinical use of hematopoietic growth factors].
Gianni
A M
AM
Divisione di Oncologia Medica, Unità Cristina Gandini, Istituto Nazionale Tumori, Milano.
Bregni
M
M
Siena
S
S
Tarella
C
C
DiNicola
M
M
Bonadonna
G
G
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000209:etiology / Q000628:therapy*; D002454:Cell Differentiation / Q000187:drug effects; D003131:Combined Modality Therapy; D006410:Hematopoiesis / Q000187:drug effects; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007239:Infections / Q000628:therapy; D007958:Leukocyte Count / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors
Impiego clinico dei fattori di crescita empoietici.